Health stocks have faced strong headwinds. The sluggish economy has caused patients to postpone elective surgery, while pharmaceutical companies have been hurt by healthcare reform and expirations of patents on blockbuster drugs. Should you avoid...
Can you buy outperformance cheaply?
Most advisors use both. Here are a few outperformers.